Use of tamoxifen in carcinoma of breast patients does not lead to the following side effects:
**Core Concept**
Tamoxifen is a selective estrogen receptor modulator (SERM) used in the treatment and prevention of breast cancer. It works by binding to estrogen receptors on breast tissue, thereby inhibiting the growth-promoting effects of estrogen on breast cancer cells.
**Why the Correct Answer is Right**
Tamoxifen's action on estrogen receptors results in a partial agonist effect on bone density, which can lead to an increased risk of osteoporosis and fractures. Conversely, tamoxifen has a partial antagonist effect on the uterus, which can lead to an increased risk of endometrial cancer. Additionally, tamoxifen can cause hot flashes, vaginal discharge, and changes in libido due to its effect on estrogen receptors in the brain and reproductive organs.
**Why Each Wrong Option is Incorrect**
**Option A:**
This option is likely incorrect because tamoxifen is known to cause thromboembolic events, including deep vein thrombosis and pulmonary embolism, due to its estrogen-like effects on the coagulation system.
**Option B:**
This option is likely incorrect because tamoxifen does not cause liver toxicity, but it can cause changes in liver function tests due to its effect on estrogen receptors in the liver.
**Option C:**
This option is likely incorrect because tamoxifen can cause cataracts and corneal changes due to its effect on estrogen receptors in the eye.
**Clinical Pearl / High-Yield Fact**
One important thing to remember is that tamoxifen's effects on estrogen receptors can vary depending on the tissue type, with some tissues exhibiting agonist effects and others exhibiting antagonist effects.
**Correct Answer: A.**